by Adrian Manz | Sep 28, 2026 | The Doctor's Dose
SpaceX Starship Reaches Orbit: The Next Test Is Turning Scale Into Profits The SpaceX Starship first orbit milestone moves a major piece of the company’s growth strategy forward. On September 28, Starship reached orbit during its 14th test flight and deployed 26...
by Adrian Manz | Sep 24, 2026 | The Doctor's Dose
Akamai’s $11.6 Billion Anthropic Deal: What Investors Should Watch Akamai Technologies has expanded its cloud relationship with Anthropic through an $11.6 billion contractual commitment over seven years. The agreement gives Akamai a much larger role in supplying the...
by Adrian Manz | Sep 24, 2026 | The Doctor's Dose
Meta’s Muse AI Agent Moves From App to Hardware—and Gives Wall Street a New Story The Muse Charm, new smart glasses and a transaction-based revenue model show how Mark Zuckerberg intends to turn Meta’s personal AI ambitions into a consumer platform. Meta Platforms is...
by Adrian Manz | Sep 24, 2026 | The Doctor's Dose
Meta Brings Muse to AI Glasses as Its Assistant Gains Momentum Meta is bringing its new personal AI agent, Muse, to its smart glasses. The announcement at Meta Connect on September 23 links two of Mark Zuckerberg’s biggest bets: an assistant that can carry out tasks...
by Adrian Manz | Sep 24, 2026 | The Doctor's Dose
Fiserv’s Turnaround: What Takis Georgakopoulos Must Prove Takis Georgakopoulos took over as Fiserv’s chief executive in June 2026 at a difficult moment for the payments and banking technology company. His predecessor, Mike Lyons, departed after roughly a year in the...
by Adrian Manz | Sep 24, 2026 | The Doctor's Dose
Nscale’s ByteDance Revenue Puts Customer Concentration in Focus Ahead of IPO Nscale is preparing to take its AI cloud business public after a rapid expansion fueled by demand for Nvidia computing power. Its IPO filing also reveals a risk investors will need to...
by Adrian Manz | Sep 3, 2026 | The Doctor's Dose
Nvidia’s $13 Billion Hugging Face Deal Pushes the AI Race Beyond Chips n Nvidia is making another major move to strengthen its position at the center of the artificial intelligence economy. The company has agreed to acquire AI model platform Hugging Face for...
by Adrian Manz | Sep 3, 2026 | The Doctor's Dose
Tesla’s Cybercab Event Could Be a Major Volatility Catalyst for TSLA Tesla’s Thursday evening Cybercab event in Austin could become one of the most important near-term catalysts for the stock, not because investors need another demonstration of autonomous-driving...
by Adrian Manz | Sep 2, 2026 | The Doctor's Dose
Market Insight · Technology & Transportation Uber Cuts 3,300 Jobs to Fund the Robotaxi Race Uber’s largest workforce reduction since the pandemic could save an estimated $825 million annually. Investors must now decide whether the restructuring represents...
by Adrian Manz | Sep 2, 2026 | The Doctor's Dose
Market Insight · Automotive Technology EV Batteries Are Going the Distance—and That Could Reshape the Used-Car Market A study covering more than 500,000 battery tests suggests that one of the electric-vehicle market’s most persistent fears may have been overstated....
